LOWELL, Mass.: To fill the growing need for clinical trials, MindLeaf Technologies developed a data management platform to help organizations recruit subjects while adhering to the FDA mandate around DEI requirements while providing patient engagement services to ensure patients will stay in the trial. The platform allows organizations at each clinical trial phase: pre-trial, recruitment, in-trial, and post-trial to collect data to provide a holistic view of the trial/site/patients.

After 2 years of development and beta testing in the market, MindLeaf is excited to announce that it will spin off the life sciences division as CliniLink Health, which will operate independently from MindLeaf Technologies. CliniLink Health will emerge as an entirely separate entity dedicated to providing data collection solutions and services that focus solely on clinical trials.

Having been in operation for over 20 years, Paresh Shah, the CEO of MindLeaf Technologies, identified a gap in the clinical trials’ patient engagement, which led to a low percentage of clinical trials completed. He quickly moved to fill the void by establishing a patient engagement platform.

The birth of CliniLink Health comes after comprehensive testing and validation by speaking to expert industry leaders and specialists. CliniLink Health will focus on revolutionizing clinical trials through services that address the needs of CROs and healthcare organizations.

Using CliniLink Health in clinical trials will help achieve better results by providing services that address every clinical trial stage. From the early planning stages to execution and data analysis, CliniLink services will facilitate the better organization of clinical trials and adequate preparation for patient recruitment, DEI, and SDOH while running clinical trials.

The company intends to achieve this by:

• Providing a technology platform to enhance the human connection between trial sites, sponsors, and other subjects.
• Providing data collection, allowing users to detect, communicate, and respond to potential issues with patients, trial sites, and trials.
• Communicating the trial outcomes with stakeholders and sponsors to ensure future trials end within budget and on time.

This new platform will offer services that include DEI analysis during patient recruitment, patient onboarding and engagement, risk management for patients dropping out, and SDOH analysis. By doing this, CliniLink Health hopes to improve the performance and outcomes of clinical trials and patient recruitment.

After the spinoff, MindLeaf Technologies will keep its primary function and mission of offering its services to federal and state government healthcare organizations. At the same time, CliniLink Health grows independently with its dedication to clinical trials.

About MindLeaf Technologies

Founded in 1993, MindLeaf Technologies, led by CEO, Paresh Shah, supports healthcare companies with medical and compliance support services. With a team of professionals, the company serves hospitals, clinics, healthcare facilities, clearinghouses, and payer organizations nationwide.

MindLeaf Technologies focus includes medical health management, medical scribes, medical appointing, medical compliance, clinical trials, medical coding and auditing, and patient management. Visit https://www.mindleaf.com for more information!

For media inquiries:
Wendy Austin
wendy@wsihds.com
203-433-5451

Fonte: Business Wire